Compare QSI & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QSI | USNA |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 371.5M |
| IPO Year | N/A | 1996 |
| Metric | QSI | USNA |
|---|---|---|
| Price | $1.27 | $19.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $2.88 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 4.2M | 172.7K |
| Earning Date | 11-05-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | $3,177,000.00 | ★ $912,670,000.00 |
| Revenue This Year | N/A | $9.87 |
| Revenue Next Year | $159.68 | N/A |
| P/E Ratio | ★ N/A | $22.16 |
| Revenue Growth | ★ 40.20 | 5.88 |
| 52 Week Low | $0.95 | $18.48 |
| 52 Week High | $5.77 | $38.32 |
| Indicator | QSI | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 43.86 |
| Support Level | $1.18 | $19.53 |
| Resistance Level | $1.31 | $20.65 |
| Average True Range (ATR) | 0.09 | 0.66 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 25.00 | 20.51 |
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.